General Practice · Brodheadsville, PA
NPI
1164535423
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
0
Medicare group memberships
Hospitals
5
Hospital affiliations
Route 209
Brodheadsville, PA, 18322
Phone (570) 992-5500
Medicare paid, 2024
$102K
1,398 services
Medicare patients, 2024
536
Average age 73
Drug cost, 2024
$1.1M
6,463 prescriptions
Company payments, 2025
$4,652
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frank G Romascavage was code 99213 (office e&m - established), 803 times for 394 patients. In total Frank G Romascavage billed 1,398 services in 11 codes, and Medicare paid $102K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 803 | 394 | $59.48 | $48K |
| 99214 Office E&M - Established | Office | 531 | 324 | $90.31 | $48K |
| 99204 Office E&M - New | Office | 23 | 23 | $114.24 | $2,628 |
By year: 2022 $112K for 1,639 services; 2023 $104K for 1,456 services; 2024 $102K for 1,398 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 12 | 11 | $3.41 | $40.92 |
Medicare prescription drug claims, 2024
In 2024, the drug Frank G Romascavage prescribed most often to Medicare patients was Amlodipine Besylate, with 288 prescriptions and refills. In total Frank G Romascavage wrote 6,463 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 288 | 752 | 80 | $1,598 |
| Atorvastatin Calcium Generic | 276 | 675 | 82 | $2,537 |
| Prednisone Generic | 273 | 273 | 175 | $516 |
| Olmesartan Medoxomil Generic | 244 | 589 | 77 | $4,422 |
| Nexlizet Bempedoic Acid/Ezetimibe | 232 | 344 | 45 | $135K |
| Levothyroxine Sodium Generic | 213 | 585 | 59 | $2,708 |
| Glipizide Generic | 210 | 459 | 55 | $1,749 |
| Metformin Hcl Generic | 158 | 360 | 43 | $850 |
| Azithromycin Generic | 145 | 145 | 93 | $665 |
| Rosuvastatin Calcium Generic | 139 | 370 | 52 | $2,654 |
| Lisinopril Generic | 138 | 334 | 36 | $900 |
| Pantoprazole Sodium Generic | 126 | 271 | 33 | $1,038 |
| Levofloxacin Generic | 107 | 107 | 64 | $694 |
| Farxiga Dapagliflozin Propanediol | 105 | 129 | 29 | $62K |
| Clonidine Hcl Generic | 95 | 183 | 26 | $422 |
Brand drugs: 1,404 claims; generic drugs: 4,877 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frank G Romascavage $4,652 ($4,652 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,168.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 47 | $1,168 |
| Pfizer Inc. PFE | 27 | $603 |
| Abbvie Inc. ABBV | 18 | $481 |
| Xeris Pharmaceuticals, Inc. | 26 | $448 |
| Aimmune Therapeutics, Inc. | 24 | $387 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $366 |
| Mannkind Corporation MNKD | 31 | $301 |
| Viatris Specialty LLC | 16 | $246 |
| Esperion Therapeutics, Inc. ESPR | 21 | $216 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $181 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.